STATE STREET CORP - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 65 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,365,437
+10.5%
191,844
+10.2%
0.00%
Q2 2023$2,141,492
+244.7%
174,105
+244.4%
0.00%
Q1 2023$621,333
-44.5%
50,556
-48.3%
0.00%
Q4 2022$1,119,780
+539.9%
97,712
+109.9%
0.00%
Q3 2022$175,000
-36.8%
46,5560.0%0.00%
Q2 2022$277,000
-5.8%
46,5560.0%0.00%
Q1 2022$294,000
+61.5%
46,5560.0%0.00%
Q4 2021$182,000
-19.1%
46,5560.0%0.00%
Q3 2021$225,000
-24.2%
46,5560.0%0.00%
Q2 2021$297,000
+324.3%
46,556
+316.2%
0.00%
Q1 2021$70,000
-9.1%
11,1850.0%0.00%
Q4 2020$77,000
+71.1%
11,1850.0%0.00%
Q3 2020$45,000
+21.6%
11,1850.0%0.00%
Q2 2020$37,000
+54.2%
11,1850.0%0.00%
Q1 2020$24,000
-31.4%
11,1850.0%0.00%
Q4 2019$35,000
-30.0%
11,1850.0%0.00%
Q3 2019$50,000
-26.5%
11,1850.0%0.00%
Q2 2019$68,000
-12.8%
11,1850.0%0.00%
Q1 2019$78,000
+81.4%
11,1850.0%0.00%
Q4 2018$43,000
-61.6%
11,185
-46.6%
0.00%
Q3 2018$112,000
+14.3%
20,958
+5.1%
0.00%
Q2 2018$98,000
-94.4%
19,939
-90.9%
0.00%
Q1 2018$1,759,000
-21.9%
218,396
-0.6%
0.00%
Q4 2017$2,251,000
-31.1%
219,665
-2.4%
0.00%
Q3 2017$3,269,000225,0070.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders